Global Cure Medicine LLC v. Alfa Pharma LLC

Filing 72

MINUTE ORDER granting in part and denying in part Plaintiff's 54 Motion in Limine; reserving for ruling Defendant's 55 Motions in Limine; granting in part and denying in part the Parties' 60 Stipulated Motion for Determination of Issues before Trial. Authorized by Judge Marsha J. Pechman. (PM)

Case 2:19-cv-00588-MJP Document 72 Filed 12/08/20 Page 1 of 2

1
2
3
4
5
6
7
UNITED STATES DISTRICT COURT
WESTERN DISTRICT OF WASHINGTON
AT SEATTLE

8
9
10

GLOBAL CURE MEDICINE LLC,
Plaintiff,

11
12
13

CASE NO. C19-588 MJP
MINUTE ORDER

v.
ALFA PHARMA LLC, SULIMAN ALFAYOUMI

14
Defendants.
15
16
17
18
19
20
21
22
23
24

The following minute order is made by the direction of the court, the Honorable Marsha
J. Pechman, United States District Judge:
During the Pretrial Conference held on December 3, 2020, the Court provided its oral
ruling on the Parties’ Motions in Limine (Dkt. Nos. 54 and 55). As set forth in full detail on the
record, the Court GRANTED in part and DENIED in part Plaintiff’s Motions in Limine as
follows: Ms. Al-Fayoumi will be permitted to testify but there will be no evidence or testimony
about any proceedings against Ms. Al-Fayoumi in Oman. The Court RESERVED RULING on
Defendants’ Motions in Limine and will consider the admissibility of the letters at trial and any

MINUTE ORDER - 1

Case 2:19-cv-00588-MJP Document 72 Filed 12/08/20 Page 2 of 2

1

testimony as to damages after the parties submit additional briefing. During the Pretrial

2

Conference on December 3, 2020, the Court GRANTED in part and DENIED in part the Motion

3

for Determination of Issues before Trial (Dkt. No. 60). As set forth in full detail on the record,

4

the Court ruled as follows: (1) the issue of merchantability of the drugs remains undecided,

5

including as to Plaintiff’s breach of the implied warranty of merchantability; (2) damages from

6

Plaintiff’s loss of its license in Oman are not recoverable, and the scope of consequential

7

damages remains to be determined after the parties will submit briefing; and (3) evidence

8

concerning investigations by the FDA and Washington Department of Health shall be excluded,

9

but evidence as to Alfa Pharma’s license status can be presented.

10

The clerk is ordered to provide copies of this order to all counsel.

11

Filed December 8, 2020.

12

William M. McCool
Clerk of Court

13

s/Paula McNabb
Deputy Clerk

14
15
16
17
18
19
20
21
22
23
24

MINUTE ORDER - 2